PMP22 frameshift mutation and hereditary neuropathy with liability to pressure palsies

Neurology

Volumn 49, Issue 5, 1997, Pages 1478-

  Pareyson, Davide ^a   Botti, Sara ^a   Sghirlanzoni, Angelo ^a   Taroni, Franco ^a  

^a NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FRAMESHIFT MUTATION; GENETICS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; NOTE; PARALYSIS; PRESSURE;

FRAMESHIFT MUTATION; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HUMANS; PARALYSIS; PRESSURE;

EID: 0031279393     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.49.5.1478     Document Type: Letter

References (13)

1. Young P, Wiebusch H, Stögbauer-F, Ringelstein B, Assmann G, Funke H. A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies. Neurology 1997;48:450-452.
2. Pareyson D, Taroni F. Deletion of the PMP22 gene and hereditary neuropathy with liability to pressure palsies. Curr Op Neurol 1996;9:348-354.
3. Nicholson GA, Valentijn LJ, Cherryson AK, et al. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nature Genet 1994;6:263-266.
4. Taroni F, Botti S, Sghirlanzoni A, Botteon G, DiDonato S, Pareyson D. A nonsense mutation in the PMP22 gene in Hereditary Neuropathy with liability to Pressure Palsies (HNPP) not associated with the 17p11.2 deletion [abstract]. Am J Hum Genet 1995;57(suppl):A229.
5. Mariman ECM, Gabreëls-Festen AAWM, van Beersum SEC, et al. Elucidation of the molecular defect causing a severe type of hereditary neuropathy with liability to pressure palsies (HNPP) in patients lacking the common 1.5 Mb deletion in chromosome 17p [abstract]. Am J Hum Genet 1995;57(suppl):A22.
6. Lenssen PPA, Gabreëls-Festen AAWM, Mariman ECM, van Engelen BGM, Gabreëls FJM. Phenotypical differences in HNPP patients with a point mutation compared to patients with a deletion [abstract]. J Neurol 1996;243(suppl 2):S18.
7. Mariman ECM, Gabreëls-Festen AAWM, van Beersum SEC, et al. Prevalence of the 1.5-Mb 17p deletion in families with hereditary neuropathy with liability to pressure palsies. Ann Neurol 1994;36:650-655.
8. Gabreëls-Festen AAWM, Gabreëls FJM, Joosten EMG, Vingerhoets HM, Renier WO. Hereditary neuropathy with liability to pressure palsies in childhood. Neuropediatrics 1992;23:138-143.
9. Funke H, von Eckardstein A, Pritchard PH, et al. Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase(LCAT) deficiency: six newly identified defective alleles further contribute to the structural heterogeneity in the disease. J Clin Invest 1993;91:677-683.
10. Funke H, von Eckardstein A, Pritchard PH, et al. A molecular defect causing fish eye disease: an amino acid exchange in lecithin: cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LACT activity. Proc Natl Acad Sci U S A 1991;88:4855-4859.
11. Seedorf U, Wiebusch H, Muntoni S, et al. A novel variant of lysosomal acid lipase (Leu336Pro) associated with acid lipase deficiency and cholesterol ester storage disease (CESD). Arterioscl Thromb Vasc Biol 1995;15:773-778.
12. Seedorf U, Wiebusch H, Muntoni S, Ertan M, Funke H, Assmann G. Wolman disease due to homozygosity for a novel truncated variant of lysosomal acid lipase (351insA) associated with complete in situ acid lipase deficiency [abstract]. Circulation 1996;8(Suppl):1-35.
13. Russell MW, Dick M, Collins FS, Brody LC. Kvlqt1 mutations in three families with familial or sporadic long QT syndrome. Hum Molec Genet 1996;5:1319-1324.